VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Community Activities
Products
Product Groups
Products A-Z
Investors
IMP stock information
Financial information
Annual Report & Sustainability Report
AGM
Corporate Governance
Information Disclosure
Analyst Report
News - Events
Community
Careers
Media
Contact
Home
Investors
AGM
Documents
IMP – Invitation and Documents of the 2020 AGM
05/13/2020
INVITATION LETTER and PROXY FORM for the 2020 AGM
Regulations for the 2020 AGM
Report and Evaluation of the BOD' Activities in 2019 – Plans for 2020
Proposal for Approval of the Audited Financial Statements for 2019
Report on Business results by the BOM in 2019 – Plans for 2020
Independent Audit Report for Shareholders
Supervisory Board Report for 2019
Proposal for the Selection of an Independent Audit Firm
Report on Operating Expenses of the BOD and Supervisory Board in 2019
Proposal for Operating Expenses of the BOD and Supervisory Board in 2020
Proposal for the Profit Distribution in 2019 and Dividend Payment Plan for 2020
Proposal for Issuance of Additional Shares to Increase Charter Capital
Proposal for the Establishment of Subcommittees under the Board of Directors
Proposal for Amendments to the Company's Charter
Proposal for Amendments to the Internal Corporate Governance Regulations at the 2020 AGM
Proposal for the Dismissal of Board Members Resigning at the 2020 AGM
Proposal for the List of Nominees for the BOD’ Replacement Election at the 2020 AGM
DRAFT – Resolution of the 2020 AGM of Imexpharm Corporation
Election Regulations – 2020 AGM
Voting Ballot
04/03/2025
IMP - Documents for the 2025 Annual General Meeting of Shareholders
03/28/2025
IMP - Announcement attend the AGM 2025
10/17/2024
IMP - Documents to collect GMS's opinions in writing (2nd time in 2024)
07/25/2024
IMP - Documents to collect GMS's opinions in writing
04/05/2024
IMP - Documents of the 2024 AGM